Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 31, 2024
Kappa opioid receptor availability predicts severity of anhedonia in schizophreniaMark Slifstein, Wenchao Qu, Roberto Gil, et al.
Archives of General Psychiatry|March 3, 2010
Increased synaptic dopamine function in associative regions of the striatum in schizophreniaLawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS studyDonald C Goff, Joseph P McEvoy, Leslie Citrome, et al.
Psychophysiology|May 12, 2010
Neuronal generator patterns of olfactory event-related brain potentials in schizophreniaJürgen Kayser, Craig E Tenke, Dolores Malaspina, et al.
Archives of General Psychiatry|January 4, 2012
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopyLawrence S Kegeles, Xiangling Mao, Arielle D Stanford, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Prefrontal dopamine D1 receptors and working memory in schizophreniaAnissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|December 10, 2009
Current source density (CSD) old/new effects during recognition memory for words and faces in schizophrenia and in healthy adultsJürgen Kayser, Craig E Tenke, Christopher J Kroppmann, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2010
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidoneW Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 7